<DOC>
	<DOCNO>NCT02622100</DOCNO>
	<brief_summary>The purpose study evaluate relative effectiveness safety Bioresorbable Vascular Scaffold compare ( drug elute stent ) DES .</brief_summary>
	<brief_title>Evaluation Effectiveness Safety Bioresorbable Vascular Scaffold Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Age 19 Intervention Bioresorbable Vascular Scaffold Agreed write informed consent form Bypass graft surgery ( CABG ) recommend Lesion previous bypass graft surgery ( CABG ) Severe calcification and/or severe tortuosity Contraindication antiplatelet agent Inability take dual antiplatelet therapy within 1 year Life expectancy 1year Subjects schedule receive cardiac surgery serious noncardiac surgery Cardiac shock</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Bioresorbable Vascular Scaffold</keyword>
	<keyword>Routine Clinical Practice</keyword>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>drug elute stent</keyword>
</DOC>